6.3.5.3	6-diazo-5-oxo-L-norleucine	-	839	
6.3.5.3	6-diazo-5-oxo-L-norleucine	competitive analogue of Gln binds irreversibly at the Gln active site	839	
6.3.5.3	ADP	-	13	
6.3.5.3	albizziin	-	10572	
6.3.5.3	albizziin	competitive analogue of Gln binds irreversibly at the Gln active site	10572	
6.3.5.3	albizziin	presence of beta-5'-phosphoribosylformylglycinamide, ATP, and Mg2+ inhibits inactivation	10572	
6.3.5.3	beta-gamma-5'-Adenylyl methylene diphosphate	-	92755	
6.3.5.3	Cyanate	-	1376	
6.3.5.3	Glu	noncompetitive with respect to Gln, competitive with respect to ATP, uncompetitive with respect to 5'-phosphoribosylformylglycinamide	343	
6.3.5.3	Glu	-	343	
6.3.5.3	hydroxylamine	-	85	
6.3.5.3	iodoacetamide	-	67	
6.3.5.3	iodoacetamide	rate of inactivation is 20-30times greater in the presence than in the absence of beta-5'-phosphoribosylformylglycinamide, ATP, and Mg2+	67	
6.3.5.3	iodoacetate	-	93	
6.3.5.3	iodoacetate	rate of inactivation is 20-30times greater in the presence than in the absence of beta-5'-phosphoribosylformylglycinamide, ATP, and Mg2+	93	
6.3.5.3	L-2-Amino-4-oxo-5-chloropentanoic acid	-	5985	
6.3.5.3	Na+	-	59	
6.3.5.3	O-diazoacetyl-L-Ser	-	30290	
6.3.5.3	O-diazoacetyl-L-Ser	i.e. L-azaserine, competitive analogue of Gln binds irreversibly at the Gln active site	30290